» Articles » PMID: 28781697

BODIPY-based Fluorescent Liposomes with Sesquiterpene Lactone Trilobolide

Overview
Specialty Chemistry
Date 2017 Aug 8
PMID 28781697
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Like thapsigargin, which is undergoing clinical trials, trilobolide is a natural product with promising anticancer and anti-inflammatory properties. Similar to thapsigargin, it has limited aqueous solubility that strongly reduces its potential medicinal applications. The targeted delivery of hydrophobic drugs can be achieved using liposome-based carriers. Therefore, we designed a traceable liposomal drug delivery system for trilobolide. The fluorescent green-emitting dye BODIPY, cholesterol and trilobolide were used to create construct . The liposomes were composed of dipalmitoyl-3-trimethylammoniumpropane and phosphatidylethanolamine. The whole system was characterized by atomic force microscopy, the average size of the liposomes was 150 nm in width and 30 nm in height. We evaluated the biological activity of construct and its liposomal formulation, both of which showed immunomodulatory properties in primary rat macrophages. The uptake and intracellular distribution of construct and its liposomal formulation was monitored by means of live-cell fluorescence microscopy in two cancer cell lines. The encapsulation of construct into the liposomes improved the drug distribution in cancer cells and was followed by cell death. This new liposomal trilobolide derivative not only retains the biological properties of pure trilobolide, but also enhances the bioavailability, and thus has potential for the use in theranostic applications.

Citing Articles

Terpenes and Terpenoids Conjugated with BODIPYs: An Overview of Biological and Chemical Properties.

Stankova J, Jurasek M, Hajduch M, Dzubak P J Nat Prod. 2024; 87(4):1306-1319.

PMID: 38482846 PMC: 11061839. DOI: 10.1021/acs.jnatprod.3c00961.


Protein encapsulation: a new approach for improving the capability of small-molecule fluorogenic probes.

Han H, Sedgwick A, Shang Y, Li N, Liu T, Li B Chem Sci. 2021; 11(4):1107-1113.

PMID: 34084367 PMC: 8145178. DOI: 10.1039/c9sc03961a.


Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment.

An D, Yu X, Jiang L, Wang R, He P, Chen N Molecules. 2021; 26(5).

PMID: 33652957 PMC: 7956628. DOI: 10.3390/molecules26051280.


Antifungal Properties of Nerolidol-Containing Liposomes in Association with Fluconazole.

Bezerra C, Geraldo de Alencar Junior J, de Lima Honorato R, Lucas Dos Santos A, Pereira da Silva J, Gusmao da Silva T Membranes (Basel). 2020; 10(9).

PMID: 32825411 PMC: 7558210. DOI: 10.3390/membranes10090194.


Cholesterol-Based Compounds: Recent Advances in Synthesis and Applications.

Albuquerque H, Santos C, Silva A Molecules. 2019; 24(1).

PMID: 30597999 PMC: 6337470. DOI: 10.3390/molecules24010116.

References
1.
Niu L, Li H, Feng L, Guan Y, Chen Y, Duan C . BODIPY-based fluorometric sensor array for the highly sensitive identification of heavy-metal ions. Anal Chim Acta. 2013; 775:93-9. DOI: 10.1016/j.aca.2013.03.013. View

2.
Ni Y, Wu J . Far-red and near infrared BODIPY dyes: synthesis and applications for fluorescent pH probes and bio-imaging. Org Biomol Chem. 2014; 12(23):3774-91. DOI: 10.1039/c3ob42554a. View

3.
Liu Y, Lok C, Ko B, Shum T, Wong M, Che C . Subcellular localization of a fluorescent artemisinin derivative to endoplasmic reticulum. Org Lett. 2010; 12(7):1420-3. DOI: 10.1021/ol902890j. View

4.
Yan J, Huang N, Li S, Yang L, Xing W, Zheng Y . Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. Bioorg Med Chem Lett. 2012; 22(5):1976-9. DOI: 10.1016/j.bmcl.2012.01.037. View

5.
Kmonickova E, Melkusova P, Harmatha J, Vokac K, Farghali H, Zidek Z . Inhibitor of sarco-endoplasmic reticulum Ca2+-ATPase thapsigargin stimulates production of nitric oxide and secretion of interferon-gamma. Eur J Pharmacol. 2008; 588(1):85-92. DOI: 10.1016/j.ejphar.2008.03.037. View